Aadi Bioscience, Inc.AADINASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR+33.6%
5Y CAGR+0.2%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+33.6%/yr
vs -5.4%/yr prior
5Y CAGR
+0.2%/yr
Recent acceleration
Acceleration
+39.0pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 65.79% |
| Q2 2025 | -141.30% |
| Q1 2025 | 374.63% |
| Q4 2024 | -42.55% |
| Q3 2024 | 12.96% |
| Q2 2024 | 20.59% |
| Q1 2024 | -13.33% |
| Q4 2023 | 0.00% |
| Q3 2023 | 10.45% |
| Q2 2023 | -31.37% |
| Q1 2023 | 1.92% |
| Q4 2022 | 17.46% |
| Q3 2022 | 27.59% |
| Q2 2022 | -31.82% |
| Q1 2022 | 14.29% |
| Q4 2021 | 91.59% |
| Q3 2021 | -1891.30% |
| Q2 2021 | 67.38% |
| Q1 2021 | 6.00% |
| Q4 2020 | -525.00% |
| Q3 2020 | 65.22% |
| Q2 2020 | -53.33% |
| Q1 2020 | 68.09% |
| Q4 2019 | 4.08% |
| Q3 2019 | 18.33% |
| Q2 2019 | 33.09% |
| Q1 2019 | 0.37% |
| Q4 2018 | -173.77% |
| Q3 2018 | 211.25% |
| Q2 2018 | 19.16% |
| Q1 2018 | -19.01% |
| Q4 2017 | -34.12% |
| Q3 2017 | 16.67% |
| Q2 2017 | -10.47% |
| Q1 2017 | -26793.20% |
| Q4 2016 | -171.05% |
| Q3 2016 | 9.52% |
| Q2 2016 | 99.82% |
| Q1 2016 | -35051.52% |
| Q4 2015 | -83.33% |